logo
Select company
Select metric
$ -3.92MNet Cash Flow - Operations
VS
Market
28
Sector
67
Industry
88
History
20
$ 0.62Close
$ 0.36 - $ 4.96 52-Week Range
Ticker Information

Ticker

IBO

Company Name

IMPACT BIOMEDICAL INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

IMPACT BIOMEDICAL INC - Net Cash Flow - Operations Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

IBO - CF - Operations Historical data
DateNet Cash Flow - Operations
6/30/2025$ -3.92M
3/31/2025$ -3.89M
12/31/2024$ -3.92M
9/30/2024$ -3.1M
6/30/2024$ -2.48M
12/31/2023$ -2.85M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • IMPACT BIOMEDICAL INC's latest trailing twelve months (TTM) CF - Operations stands at $ -2.85M.
  • Over the past 5 years, IMPACT BIOMEDICAL INC's average CF - Operations has been $ -3.36M.
  • The median CF - Operations for IMPACT BIOMEDICAL INC during this period was $ -3.49M
  • IMPACT BIOMEDICAL INC reached its highest CF - Operations over the past 5 years at $ -2.48M.
  • The lowest CF - Operations recorded by IMPACT BIOMEDICAL INC in the same timeframe $ -3.92M

IMPACT BIOMEDICAL INC's CF - Operations vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Operations Benchmarks
CompanyCF - Operations
CELZ : CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC $ -5.69MTCRT : ALAUNOS THERAPEUTICS INC $ -2.85MADTX : ADITXT INC $ -22.61MHSCS : HEARTSCIENCES INC $ -7.35MPMCB : PHARMACYTE BIOTECH INC $ -4.6MAPVO : APTEVO THERAPEUTICS INC $ -24.65MPALI : PALISADE BIO INC $ -9.66MACXP : ACURX PHARMACEUTICALS INC $ -8.16MGNPX : GENPREX INC $ -14.08MTTNP : TITAN PHARMACEUTICALS INC $ -2.75M

Definition of Net Cash Flow - Operations

[Cash Flow Statement] Cash flow from operations represents the amount of cash inflow (outflow) that a company generates (consumes) from operating activities. Similar to Net Income [NetIncCmn] but harder to manipulate and ignoring effects of non-cash charges like depreciation.

IBO - Net Cash Flow - Operations, Last 5 years

$ -3.92M

Minimum

Dec 31, 2024

$ -2.48M

Maximum

Jun 30, 2024

$ -3.36M

Average

$ -3.49M

Median

CF - Operations Benchmark Analysis

The chart above depicts the distribution of CF - Operations for companies in the Total Stock Market. The average CF - Operations of the companies is $ 58.3M with a standard deviation of $ 142.13M.
The following table provides additional summary stats:
CF - Operations in the Market:
filtered constituents3.26K
min$ -406M
max$ 508.1M
average$ 58.3M
median$ 10.91M
std$ 142.13M